Multiplex Assay Kit for Interleukin 1 Family, Member 9 (IL1F9) ,etc. by FLIA (Flow Luminescence Immunoassay)

IL-1F9; IL36g; IL-1H1; IL-1RP2; IL1E; IL1H1; IL1RP2; Interleukin 36, Gamma; Interleukin-1 Homolog 1; Interleukin-1 epsilon; Interleukin 1-Related Protein 2

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Interleukin 1 Family, Member 9 (IL1F9) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Interleukin 1 Family, Member 9 (IL1F9) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Interleukin 1 Family, Member 9 (IL1F9) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Interleukin 1 Family, Member 9 (IL1F9) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 95-103 99
EDTA plasma(n=5) 93-103 97
heparin plasma(n=5) 79-101 91

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Interleukin 1 Family, Member 9 (IL1F9) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Interleukin 1 Family, Member 9 (IL1F9) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Interleukin 1 Family, Member 9 (IL1F9) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 89-96% 78-104% 82-95% 79-105%
EDTA plasma(n=5) 78-94% 98-105% 82-89% 90-97%
heparin plasma(n=5) 91-101% 84-92% 86-97% 90-97%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:IL1F9) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
PLOS ONE Interleukin (IL)-1β Is a Strong Inducer of IL-36γ Expression in Human Colonic Myofibroblasts PubMed: 26562662
Journal of Investigative Dermatology Increased interleukin‐36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome Pubmed:29314201
Journal of Investigative Dermatology For Review Only
international immunopharmacology Acitretin inhibits IL-17A-induced IL-36 expression in keratinocytes by down-regulating IκBζ Pubmed: 31863918
J Agric Food Chem Inhibition of HMGB1/TLR4 Signaling Pathway by Digitoflavone: A Potential Therapeutic Role in Alcohol-Associated Liver Disease Pubmed:35212223
Br J Pharmacol Modulation of IL‐36‐based inflammatory feedback loop through hepatocytes‐derived IL‐36R‐P2X7R axis improves steatosis in alcoholic steatohepatitis Pubmed:35481896
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
APL621Hu01 Active Interleukin 1 Family, Member 9 (IL1F9) Cell culture; Activity Assays.
RPL621Hu01 Recombinant Interleukin 1 Family, Member 9 (IL1F9) Positive Control; Immunogen; SDS-PAGE; WB.
PAL621Hu01 Polyclonal Antibody to Interleukin 1 Family, Member 9 (IL1F9) WB; IHC; ICC; IP.
LAL621Hu71 Biotin-Linked Polyclonal Antibody to Interleukin 1 Family, Member 9 (IL1F9) WB; IHC; ICC.
MAL621Hu22 Monoclonal Antibody to Interleukin 1 Family, Member 9 (IL1F9) WB; IHC; ICC; IP.
MAL621Hu21 Monoclonal Antibody to Interleukin 1 Family, Member 9 (IL1F9) WB; IHC; ICC; IP.
SEL621Hu ELISA Kit for Interleukin 1 Family, Member 9 (IL1F9) Enzyme-linked immunosorbent assay for Antigen Detection.
SCL621Hu CLIA Kit for Interleukin 1 Family, Member 9 (IL1F9) Chemiluminescent immunoassay for Antigen Detection.
LML621Hu Multiplex Assay Kit for Interleukin 1 Family, Member 9 (IL1F9) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.